{"url_path":"/sec/stok/8-k/2026-06-30/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-30","source_url":"https://www.sec.gov/Archives/edgar/data/1623526/0001193125-26-289409-index.html","accession_number":"0001193125-26-289409","cik":"0001623526","ticker":"STOK","issuer_name":"Stoke Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1623526/0001193125-26-289409-index.html","primary_entity_key":"0001623526","primary_entity_name":"Stoke Therapeutics, Inc."},"word_count":85,"has_tables":true,"body_markdown":"Item 9.01\n\nFinancial Statements and Exhibits.\n\n(d) Exhibits\n\n \n\nExhibit\n\nNumber\n\n  \nDescription\n\n99.1\n  \n[Press Release dated June 30, 2026](d924679dex991.htm)\n\n104\n  \nCover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\n \nSTOKE THERAPEUTICS, INC.\n\nDate: June 30, 2026\n \n\n \nBy:\n \n\n/s/ Thomas E. Leggett\n\n \n\n \n\n \n\nThomas E. Leggett\n\nChief Financial Officer"}